Celltrion buys France’s Gifrer to expand beyond biosimilars
0
World

Celltrion buys France’s Gifrer to expand beyond biosimilars

May 12, 2026
Scroll

Posted 2 hours ago by

Celltrion said Tuesday it acquired French health care company Gifrer as the Korean biopharmaceutical firm expands its European business to include generics and over-the-counter products. Gifrer operates more than 9,000 pharmacy sales channels and supply networks covering about 800 hospitals across France. The company sells over 140 OTC medicines, health supplements and consumer health care products, including saline solutions, teeth-whitening products, and infant care items with strong local mar

Celltrion buys France’s Gifrer to expand beyond biosimilars
The korea Herald News
The korea Herald News

Coverage and analysis from South Korea. All insights are generated by our AI narrative analysis engine.

South Korea
Bias: center

Explore More